-Koji Morita Researcher Activity Profile

Research Author Detailed Information 

Koji Morita Publication Rate By Year

Koji Morita has published 2 paper(s) in 2006, 4 paper(s) in 2007, 1 paper(s) in 2008, for a total of 7 research publications in total.

Koji K Morita Author Information

LAST NAME: morita

FIRST NAME: koji

INITIALS: K

AFFILIATION:

Papers

Koji Morita's Publication Record

1. Comparison between properties of 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) phosphorothioate oligonucleotides and N3'-P5' thiophosphoramidate oligonucleotides. Year Published: 2006
Sankyo Co., Ltd., Lead Discovery Research Laboratories, Shinagawa-ku, Tokyo, Japan.
2. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts. Year Published: 2007
Department of Anaesthesiology and Intensive Care, Hamamatsu University School of Medicine, 1-20-1, Handayama, Hamamatsu, Shizuoka 431-3192, Japan. okadah@hama-med.ac.jp
3. The influence of hemorrhagic shock on the minimum alveolar anesthetic concentration of isoflurane in a swine model. Year Published: 2007
Department of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, Hamamatsu, Japan. tadkur@hama-med.ac.jp
4. Biologically Stable 2-5A Analogues containing 3'-O,4'-C-bridged Adenosine as Potent RNase L Agonists. Year Published: 2007
Exploratory Chemistry Research Laboratories, Sankyo Co., Ltd.,Tokyo 140-8710, Japan.
5. The influence of hemorrhagic shock on the minimum alveolar anesthetic concentration of isoflurane in a swine model. Year Published: 2007
Department of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, Hamamatsu, Japan. tadkur@hama-med.ac.jp
6. Comparison between properties of 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) phosphorothioate oligonucleotides and N3'-P5' thiophosphoramidate oligonucleotides. Year Published: 2006
Sankyo Co., Ltd., Lead Discovery Research Laboratories, Shinagawa-ku, Tokyo, Japan.
7. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas. Year Published: 2008
Department of Nephrology and Endocrinology, University of Tokyo Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.